Altogether, the present data point towards the PEDF/NFκB reciprocal regulatory axis as a key factor underpinning PEDF anti-metastatic action in pre-menopausal TNBC and post-menopausal ER+/HER2- BC cells that has not been previously described. This evidence concerns the gene NFKB1 and breast cancer.